For example, LINC00511 showed oncogenic function in ER-negative BC via interaction with EZH2 and recruiting PRC2 to mediate H3K27me3 modification in the promoter region of CDKN1B, which led to the suppression of CDKN1B expression. Here, LINC00511 is linked to breast cancer.